• Home
• EUROlinkCAT
• *PARENTS AREA*
• Infographics
• EUROlinkCAT Results Explorer
• WP 1 - Co-ordination & Management
• WP 2 - Building Results Repository
• WP 3 - Survival
• WP 4 - Morbidity
• WP 5 - Education
• WP 6 - Accuracy of Coding
• WP 7 - ConnectEpeople
• WP 8 - Dissemination
• WP 9 - Ethics Requirements
• Publications
• WP1 Protocol Paper
• WP2 Linkage Paper
• WP3 Systematic Review
• WP3 Ten-year Survival Paper
• WP3 Rare Structural Survival Paper
• WP3 Temporal and Geographical Variations Paper
• WP4 Cardiac Medications Paper
• WP4 Feeding Tubes Paper
• WP4 Length of Stay Paper
• WP5 Systematic Review
• WP8 Focus Group Paper
• WP8 COVID-19 Paper
• Submitted version of papers prior to publication
• Study Partners
• Useful Links
• Contact Information & Data Requests

Prescription of cardiovascular medication in children with congenital heart defects across six European Regions from 2000 to 2014: data from the EUROlinkCAT population-based cohort study

Lay Summary

In progress.

Full paper

https://doi.org/10.1136/bmjopen-2021-057400

Submitted version of paper prior to publication